Ludwig Kappos Selected Research

Alemtuzumab (Campath)

1/2022	Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study.
12/2016	Interdisciplinary Risk Management in the Treatment of Multiple Sclerosis.
11/2012	Alemtuzumab for multiple sclerosis: who and when to treat?

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Ludwig Kappos Research Topics

Disease

214	Multiple Sclerosis 05/2024 - 01/2003
76	Relapsing-Remitting Multiple Sclerosis 12/2023 - 05/2003
20	Chronic Progressive Multiple Sclerosis 07/2023 - 12/2010
18	Infections 10/2023 - 02/2010
16	Disease Progression 07/2023 - 06/2004
15	Atrophy 01/2024 - 12/2010
10	Progressive Multifocal Leukoencephalopathy 01/2021 - 01/2008
9	Inflammation (Inflammations) 01/2024 - 02/2007
9	Bradycardia 10/2018 - 02/2010
7	Atrioventricular Block 11/2019 - 02/2010
6	Lymphopenia (Lymphocytopenia) 01/2022 - 06/2014
5	Stroke (Strokes) 01/2024 - 09/2004
5	Fatigue 01/2021 - 03/2006
5	Human Influenza (Influenza) 01/2019 - 02/2011
4	Demyelinating Diseases (Demyelinating Disease) 02/2024 - 12/2011
4	Herpes Zoster 01/2018 - 02/2010
4	Hypertension (High Blood Pressure) 01/2018 - 02/2010
4	Neoplasms (Cancer) 01/2017 - 06/2014
4	Headache (Headaches) 10/2016 - 10/2008
3	Ganglion Cysts (Ganglion) 02/2024 - 04/2023
3	Body Weight (Weight, Body) 10/2023 - 01/2021
3	Neuromyelitis Optica (Devic's Disease) 01/2023 - 03/2015
3	Autoimmune Diseases (Autoimmune Disease) 01/2023 - 12/2016
3	Abdominal Pain (Pain, Abdominal) 12/2021 - 10/2008
3	Respiratory Tract Infections (Respiratory Tract Infection) 12/2021 - 10/2014
3	Macular Edema 06/2021 - 02/2010
3	Flushing 05/2019 - 10/2008
3	Diarrhea 01/2016 - 10/2011
3	Nausea 01/2016 - 10/2011
2	Pancreatitis 04/2024 - 12/2021
2	Experimental Autoimmune Encephalomyelitis (Encephalomyelitis, Autoimmune Experimental) 01/2024 - 01/2008
2	Neuroinflammatory Diseases 01/2024 - 01/2019
2	Nervous System Diseases (Neurological Disorders) 01/2024 - 10/2018
2	Acute Disease 07/2023 - 01/2022
2	Central Nervous System Diseases (CNS Diseases) 01/2023 - 01/2017
2	Myasthenia Gravis 11/2022 - 01/2019
2	Rett Syndrome (Rett's Disorder) 03/2022 - 01/2021
2	Nasopharyngitis 12/2021 - 10/2016
2	Opportunistic Infections (Opportunistic Infection) 11/2019 - 05/2007
2	Exanthema (Rash) 05/2019 - 10/2015

Drug/Important Bio-Agent (IBA)

47	Fingolimod Hydrochloride (FTY720)FDA Link 09/2023 - 09/2006
38	Biomarkers (Surrogate Marker)IBA 02/2024 - 12/2010
32	Natalizumab (Tysabri)FDA Link 01/2023 - 03/2006
29	teriflunomideIBA 04/2024 - 10/2011
26	Dimethyl FumarateIBA 01/2022 - 10/2008
22	InterferonsIBA 02/2021 - 05/2003
19	Interferon beta-1a FDA Link 01/2024 - 10/2007
18	ocrelizumabIBA 10/2023 - 11/2011
16	AntibodiesIBA 01/2023 - 01/2007
15	Interferon beta-1b (Betaseron)FDA Link 01/2020 - 08/2007
12	Interferon-betaIBA 01/2021 - 02/2004
11	siponimodIBA 09/2022 - 08/2013
11	GadoliniumIBA 01/2022 - 11/2012
10	Monoclonal AntibodiesIBA 10/2023 - 01/2008
10	Immunoglobulin G (IgG)IBA 01/2023 - 01/2007
8	ozanimodIBA 10/2022 - 01/2019
8	EnzymesIBA 12/2021 - 02/2010
7	Immunoglobulins (Immunoglobulin)IBA 01/2024 - 02/2011
7	Myelin-Oligodendrocyte GlycoproteinIBA 01/2023 - 01/2007
7	Sphingosine-1-Phosphate ReceptorsIBA 09/2022 - 05/2014
7	Immunologic Factors (Immunomodulators)IBA 01/2020 - 02/2012
6	Proteins (Proteins, Gene)FDA Link 07/2023 - 06/2015
6	AntigensIBA 11/2022 - 02/2011
5	Immunoglobulin M (IgM)IBA 12/2023 - 01/2007
5	Complement System Proteins (Complement)IBA 12/2023 - 01/2011
5	ofatumumab FDA Link 10/2023 - 01/2020
5	Glatiramer Acetate (Copaxone)FDA Link 01/2021 - 11/2006
5	Daclizumab (Zenapax)FDA Link 01/2021 - 09/2016
5	Transaminases (Aminotransferases)IBA 01/2018 - 09/2012
5	Neutralizing AntibodiesIBA 06/2012 - 02/2004
4	IronIBA 02/2024 - 11/2014
4	laquinimodIBA 01/2020 - 03/2012
4	Alanine Transaminase (SGPT)IBA 01/2016 - 03/2014
4	Therapeutic UsesIBA 08/2013 - 02/2004
3	Retinaldehyde (Retinal)IBA 02/2024 - 04/2023
3	Oligoclonal BandsIBA 01/2023 - 04/2015
3	Cytidine Diphosphate (CDP)IBA 01/2022 - 01/2018
3	Alemtuzumab (Campath)FDA Link 01/2022 - 11/2012
3	Vitamin D FDA LinkGeneric 01/2020 - 03/2014
3	hydroxide ionIBA 01/2019 - 08/2014
3	MicroRNAs (MicroRNA)IBA 06/2016 - 07/2012
3	temelimabIBA 10/2015 - 06/2015
3	Influenza Vaccines (Influenza Vaccine)FDA Link 03/2015 - 02/2011
3	Neuroprotective AgentsIBA 03/2015 - 09/2004
3	ImmunosorbentsIBA 10/2013 - 01/2013
2	insulin receptor-related receptor (IRR)IBA 01/2024 - 05/2019
2	Surface Antigens (Surface Antigen)IBA 12/2023 - 09/2009
2	Cladribine FDA LinkGeneric 01/2022 - 01/2020
2	Rituximab (Mabthera)FDA Link 01/2022 - 01/2019
2	VaccinesIBA 11/2021 - 10/2014
2	Minocycline (Cyclops)FDA LinkGeneric 01/2020 - 03/2015
2	CytokinesIBA 01/2020 - 12/2007
2	Matrix Metalloproteinases (MMPs)IBA 01/2020 - 02/2004
2	Hemagglutinins (Hemagglutinin)IBA 01/2019 - 01/2017

Therapy/Procedure

57	Therapeutics 05/2024 - 02/2004
5	Immunomodulation 10/2019 - 06/2004
3	Cognitive Training 01/2015 - 06/2006
2	Immunotherapy 01/2023 - 01/2019
2	Treatment Delay 01/2022 - 11/2009
2	Precision Medicine 11/2021 - 09/2021